This announcement is a separate document:
Zelira Therapeutics Ltd: HOPE SPV receives US$681,000 third tranche of funding
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.